AMCAP™: Evolving the enzymatic mRNA manufacturing

AMCAPTM: Evolving the enzymatic mRNA manufacturing

Innovative one-pot technology for cost-efficient, fast, and superior mRNA synthesis.

This webinar unveils Anemocyte’s branded AMCAP™ pioneering platform, a powerful solution that innovate the RNA manufacturing industry. AMCAP™ poses to address scalability and efficiency challenges in mRNA manufacturing, by consolidating the IVT and capping steps into a single “one-pot” enzymatic reactions that delivers high-quality mRNA in a rapid, costs-efficient, and flexible process. Attendees will gain insights into current state-of-the-art and challenges of the mRNA industry, see comparative results of various mRNA manufacturing and learn about AMCAP™ and Anemocyte solutions for RNA manufacturing in a wide range of laboratory to clinical applications.

What's the programme?

Intro: Dr. Marco Pupo, Anemocyte I&D Coordinator; Speaker: Dr. Massimo Carraro, Anemocye I&D Scientist

Speaker

Dr. Marco Pupo

Coordinator, Innovation & Development at Anemocyte

Marco Pupo is the coordinator of process development overseeing the mRNA divisions at Anemocyte. His department handles a variety of different R&D grade projects for companies across world. These include proof of concept, smooth transition from R&D to GMP technology patenting. His professional background encompasses both research, purification, and analytical development for mammalian molecular, cellular and RNA biology.

Dr. Massimo Carraro

Scientist, Innovation & Development at Anemocyte

Massimo Carraro is part of the scientific team developing AMCAP^TM in the mRNA divisions at Anemocyte. His expertise in the mRNA field is further enhanced by its research background from the CPR Novo Nordisk Foundation Center in Denmark. Massimo's academic credentials include an M.Sc. in Molecular Biology from University of Bologna and a Ph.D. in Molecular Mechanism of Diseases, from the University of Copenhagen.

This webinar is tailored for

Researcher and Industry professionals

Get the materials

Fill out the form to learn more:
Get the webinar materials

Join Anemocyte’s webinars. Gain deep insights from industry experts into the latest challenges in mRNA and pDNA manufacturing

Privacy Notice Acknowledgment and Data Processing Authorization I have read and understood the Privacy Notice and I consent to the processing of my personal data required for the operational management and organization of the webinar/event, as described in purpose (4) of the notice.

Consent for Marketing Purposes and Promotional Communications Having read and understood the Privacy Notice , with specific reference to the webinar/event for which I am registering, I consent to be contacted by Anemocyte S.r.l. via email and, if provided, by telephone, to receive promotional and commercial communications, including invitations to trade fairs, webinars, and other events, newsletters, customer satisfaction surveys, as well as information on products and services of Anemocyte S.r.l. and its affiliates in the life sciences research, biopharmaceutical, and applied industry sectors.

Consent for Image/Voice Processing (Release Form) Having read and understood the Privacy Notice and the attached Release Form , with specific reference to the webinar/event for which I am registering, I consent (where provided by the event/webinar organization) to the processing of my image and/or my voice through photographs, filming, audio and/or video recordings—including, where applicable, the recording of the webinar/event in which I participate. This includes the related broadcast (live or delayed), on-demand availability, full or partial publication, and communication to the public via the Controller’s corporate communication channels and any pages, materials, or platforms dedicated to the event.

Please note: If the event/webinar involves the recording of your image or voice, any failure to provide consent (or its subsequent withdrawal) may make it impossible to participate in or access the session, particularly in active mode (video/audio interventions). In the case of a webinar, the data subject may still protect their privacy by keeping their webcam and microphone deactivated, unless these functions are already disabled by the organizer.